Published in Hepatitis Weekly, November 25th, 2002
Scientists know that hepatoma-derived growth factor energizes the proliferation of liver cancer cells. They suspect that antisense oligonucleotides could be used for blocking hepatoma growth factor expression, which would in turn block cancer growth.
Studies of antisense oligonucleotide to hepatoma-derived growth factor have proven it slows liver cancer cell proliferation in several cell lines, according to Y. Kishima and colleagues, Osaka University Graduate School of Medicine, Osaka, Japan.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.